Efficacy of End-Effector Robot-Assisted Gait Training Combined With Robotic Balance Training in Subacute Stroke Patients
Stroke

About this trial
This is an interventional treatment trial for Stroke focused on measuring Stroke, Robotics, Gait Training, Rehabilitation, Balance, Functional Recovery, Robot-Assisted Gait Training
Eligibility Criteria
Inclusion Criteria:
- first cerebral stroke
- 1 month up to 6 months post the acute event (subacute patients)
- age between 18-85 years
- ability to fit into the end-effector footplates
- no significant limitation of joint range of motion
- ability to tolerate upright standing for 60 seconds
- ability to walk unassisted or with little assistance
- ability to give written consent
- compliance with the study procedures
Exclusion Criteria:
- contractures of the hip, knee, or ankle joints that might limit the range of motion during gait
- medical issue that precludes full weight bearing and ambulation (e.g. orthopaedic injuries, pain, severe osteoporosis, or severe spasticity)
- cognitive and/or communicative disability (e.g. due to brain injury): inability to understand the instructions required for the study
- cardiac pathologies, anxiety or psychosis that might interfere with the use of the equipment or testing
Sites / Locations
- Don Gnocchi Foundation
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Experimental 1: Gait Group (GG)
Experimental 2: Balance Group (GHG)
Gait Group (GG) will perform, in addition to conventional therapy, gait training using only an end effector robotic device for Robot-Assisted Gait Training (RAGT), 3 times/week for 12 sessions/month. During the training, patients will be asked to walk, at a varying speed, for 45 minutes and a partial Body Weight Support (BWS). Participants will start with 30-40% of BWS and an initial speed of 1.5 km/h; increasing to a maximum of between 2.2 and 2.5 km/ h and reducing the initial BWS to 15%. The therapist will provide any help during sessions if required. Over 45 minutes, the patient simulates a minimum of 300 steps; patients could rest during the session, though they will be asked to walk continuously for a minimum of 5 minutes during each session.
Balance Group (GHG) will receive, in addition to conventional therapy, a combined robotic treatment program with the same end-effector robotic system and a robotic proprioceptive platform, 3 times/week for 12 sessions/month. The time of the single session (45 minutes) is dived in gait training and balance training. The balance training will consist in static and dynamic exercises during sitting and standing position, dual-task exercises and exercises aimed to improve trunk control.